This Is The One Fentanyl Citrate Solubility UK Trick Every Person Should Be Aware Of

Understanding the Solubility of Fentanyl Citrate: A Technical Overview for UK Pharmaceutical Contexts

Disclaimer: This short article is meant for educational and expert information functions just. Fentanyl citrate is a Class A regulated substance in the United Kingdom under the Misuse of Drugs Act 1971. Handling and solution should just be carried out by certified experts in regulated environments.

In the realm of pharmacology and medical medicine, fentanyl citrate remains among the most powerful synthetic opioids offered. Due to its high efficacy and fast start of action, it is a cornerstone of pain management and anaesthesia in the UK's National Health Service (NHS) and personal health care sectors. However, the pharmacological efficiency of any drug is fundamentally linked to its physicochemical homes-- particularly its solubility.

Comprehending the solubility of fentanyl citrate is essential for pharmacists, researchers, and clinicians to make sure stable formulations, precise dosing, and effective drug shipment throughout various administration routes.


What is Fentanyl Citrate?

Fentanyl citrate is the citrate salt of fentanyl, a phenylpiperidine derivative. While fentanyl base is highly lipophilic (fat-soluble), it possesses minimal solubility in aqueous environments. By reacting the base with citric acid, moving into the salt type (fentanyl citrate), the solubility in water is substantially boosted. This makes it appropriate for intravenous (IV), intramuscular (IM), and transdermal applications.

In the UK, fentanyl citrate is made according to the requirements set by the British Pharmacopoeia (BP). It usually appears as a white, crystalline powder or as granules that are odorless.

Key Physicochemical Properties

Property

Value/Description

Chemical Formula

₤ C _ 22 H _ 28 N _ 2 O \ cdot C _ 6 H _ 8 O _ 7 ₤

Molecular Weight

528.6 g/mol

CAS Number

990-73-8

pKa

Roughly 8.4 (at 25 ° C

)Appearance White crystalline powder Octanol-Water Partition Coefficient(Log P)~ 4.05(base

)Solubility Profile in Various Solvents The solubility of fentanyl citrate varies dramatically depending


on the solvent used and the ambient temperature. In

a pharmaceutical setting, water is the main solvent of interest for injectables, but natural solvents are frequently used during the manufacturing of transdermal spots or nasal sprays. Aqueous Solubility In the UK medical context, fentanyl citrate is most commonly experienced as a 50 mcg/mL solution for injection. At room temperature(around 20 ° C to 25 ° C), fentanyl

citrate is considered"moderately soluble"in water. Scientific literature usually suggests a solubility limitation of approximately 25 mg/mL in water at 25 ° C, which is more than enough for basic scientific concentrations. Organic Solvent Solubility Fentanyl citrate exhibits different solubility in organic solvents, which is crucial for formulating non-aqueous drug shipment systems. Table 1: Solubility

of Fentanyl Citrate in Common Solvents at 25 ° C Solvent Solubility Category(approx.)Quantitative Estimate Water Sparingly Soluble ~ 25 mg/mL Methanol Freely Soluble > 100 mg/mL Ethanol(95 %) Soluble ~ 10-- 30 mg/mL Chloroform Soluble ~ 20-- 30 mg/mL Isopropyl Alcohol Somewhat Soluble

<10 mg/mL Aspects Influencing Solubility and Stability The solubility of fentanyl citrate is not a fixed value; it

is affected by numerous ecological and chemical elements that need to be controlled throughout compounding and

storage.

1. The Impact of pH As the

>citrate salt of a

weak base, the solubility of fentanyl is extremely pH-dependent. Acidic Environments: Fentanyl citrate stays extremely soluble in acidic to neutral services. A lot of UK-licensed fentanyl injections are buffered to a pH series of

4.0 to 7.5. Alkaline Environments: If the pH of an option rises considerably above 7.5, there is a danger that the fentanyl


will transition back into its base kind. Because the base

kind is substantially less soluble in water, this can lead to"crashing out"or rainfall, which is exceptionally harmful in an IV setting. 2. Temperature level Effects Like many crystalline solids, the solubility of fentanyl citrate increases with temperature. While this is valuable during the commercial dissolution process, it postures a threat throughout storage . If a saturated service is prepared at a heat and after that cooled (such as throughout transport in cold UK winter seasons), the solute may take shape. 3. Existence of Other Ions(Common **Ion Effect )The existence of other citrate salts in the solution can decrease the solubility of fentanyl citrate due to the typical ion impact. This is a vital consideration when mixing fentanyl with other medications in a syringe or infusion bag. 4. Buffer Capacity The choice of buffer(e.g., sodium citrate or phosphate buffers)is

critical in maintaining a stable environment where the drug remains in its ionized, soluble form. Developing for the UK Market: British Pharmacopoeia Standards In the United Kingdom, medicinal items should abide by the British Pharmacopoeia(BP). The BP offers specific monographs for Fentanyl Citrate, guaranteeing pureness, effectiveness, and solubility requirements are satisfied. Secret Compounding and Formulation Rules: Clarity of Solution: The BP requires that parenteral solutions be clear and devoid of noticeable particles. This is accomplished by making sure the concentration stays well listed below the saturation point. Sterility: Given the aqueous nature of the solution, formulations need to be

### sterilized, generally

through autoclaving or filtering, which can affect the stability if the solubility limitations are tight. Excipients: Common additives in UK fentanyl solutions include Sodium Chloride( for isotonicity

)and Sodium Hydroxide or Hydrochloric Acid (for pH adjustment). [Legal Fentanyl UK](https://clifford-kolding-2.hubstack.net/10-easy-ways-to-figure-out-your-fentanyl-liquid-uk) of Solubility Knowledge Why does a deep understanding of fentanyl citrate's solubility matter to the health care professional? Preventing Precipitation: Knowing that fentanyl is incompatible with highly alkaline

**services(like thiopentone or some bicarbonate options

*   **)avoids the formation of precipitates that might trigger embolic events. Enhancing Drug Delivery: In the advancement of sublingual or buccal tablets (e.g., Abstral or Effentora used in the UK), the drug needs to liquify*   **rapidly in the small volume of saliva available. Transdermal Flux: While patches depend on the lipophilicity of the fentanyl base, the manufacture of these patches typically involves dissolving the citrate salt in an unstable solvent*   **before it is fertilized into the adhesive matrix. Storage and Handling Recommendations To preserve the solubility and effectiveness of fentanyl citrate products, the following guidelines are normally

            * * *

            followed in British scientific settings: Temperature
            ----------------------------------------------------

            Control: Store at regulated room temperature (15 ° C to 25 ° C). Prevent freezing, as this can lead to irreversible precipitation in**particular formulas. Light** Protection: Fentanyl citrate is rather light-sensitive. Liquid solutions must be kept in amber glass or opaque product packaging. Dealing with Potency: Because of its high solubility and effectiveness, unexpected skin contact*   **with focused services** can lead to systemic absorption. Professional PPE is obligatory. Often Asked Questions(FAQ)Is fentanyl citrate more soluble than fentanyl base? Yes, substantially.
            *   **The citrate salt is designed specifically to increase aqueous solubility, making it appropriate for injections. The base kind is highly lipophilic and is usually utilized in the internal layers of transdermal spots. Does the UK BP(British Pharmacopoeia)differ

                from the USP relating to solubility? The basic

                solubility profiles equal as they explain the very same chemical entity. Nevertheless, the specific screening techniques and the prioritized solvents for pureness testing may vary

                *   **somewhat between the BP** and the United States Pharmacopeia (USP). Can I blend fentanyl citrate with saline? Yes. Fentanyl citrate works with 0.9%Sodium Chloride(Normal**Saline )and 5%Dextrose. These are standard diluents utilized in UK hospitals. What happens if a fentanyl solution ends up being cloudy? If a service of fentanyl citrate appears cloudy or includes** crystals, it needs to be discarded. This shows that the drug has actually sped up out of the service, either due to pH modifications, temperature level shifts, or contamination.

                * * *

                Why is citric acid utilized specifically?
                -----------------------------------------

                ### Citric acid is a well-tolerated, pharmaceutical-grade organic acid. It forms a steady salt with fentanyl that provides a balance of high water solubility and compatible pH for human tissue. Fentanyl citrate is an important pharmacological tool in the UK, but its safety and effectiveness are predicated on

                ### its chemical stability. Solubility is possibly the most crucial factor in this regard

                . By preserving an ideal pH, picking the appropriate solvents, and sticking to British Pharmacopoeia standards, the pharmaceutical industry makes sure that this potent analgesic stays a reputable alternative for patient care.

                ### For clinicians, the takeaway is simple: constantly validate compatibility before mixing and ensure storage conditions are strictly satisfied to prevent the drug from losing its soluble state.  
                ![](https://medicstoregb.uk/wp-content/uploads/2025/09/cropped-WhatsApp-Image-2025-11-22-at-2.39.06-AM.jpeg.webp)







                ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

                **

            ******

**


-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

****


Edit

Pub: 20 May 2026 10:12 UTC

Views: 2